Factors that predict site of outflow target artery anastomosis in infrainguinal revascularization

Journal of Vascular Surgery

Volumn 35, Issue 6, 2002, Pages 1093-1099

  Raffetto, Joseph D ^a,b,c   Chen, Morgan N ^a,b   LaMorte, Wayne W ^a,b   Seidman, Craig S ^a,b   Eberhardt, Robert T ^a,b   Woodson, Jonathan ^a,b   Gibbons, Gary W ^a,b   Menzoian, James O ^a,b  

^a Boston University Medical Center ^*

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY ANASTOMOSIS; ARTERY BLOOD FLOW; BYPASS SURGERY; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CLAUDICATION; CONTROLLED STUDY; DEMOGRAPHY; HUMAN; INGUINAL REGION; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; POPLITEAL ARTERY; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; RISK FACTOR; SMOKING; SURGICAL MORTALITY; TREATMENT INDICATION; ANGIOGRAPHY; ARTERY DISEASE; ARTERY OCCLUSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; NOTE; TIBIAL ARTERY; TREATMENT PLANNING; AGED; ARTERIOVENOUS SHUNT; ARTICLE; FEMALE; INTERMITTENT CLAUDICATION; LEG; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASE; RETROSPECTIVE STUDY; STATISTICAL MODEL; VASCULARIZATION;

AGED; ARTERIOVENOUS SHUNT, SURGICAL; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; LEG; LOGISTIC MODELS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; RETROSPECTIVE STUDIES; RISK FACTORS; TIBIAL ARTERIES;

EID: 33846215618     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.124375     Document Type: Article

References (21)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA 1979;241:2035-8.
2. Kannel WB, D'Agostino RB, Wilson TWF, Belanger AJ, Gagnon DR. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J 1990;120:672-6.
3. Beach KW, Strandness DE. Arteriosclerosis obliterans and associated risk factors in insulin-dependent and non-insulin-dependent diabetes. Diabetes 1980;29:882-8.
4. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease: the San Luis Valley diabetes study. Circulation 1995;91:1472-9.
5. Hooi JD, Kester AD, Stoffers HE, Overdijk MM, van Ree JW, Knottnerus J. Incidence of and risk factors for asymptomatic peripheral occlusive disease: a longitudinal study. Am J Epidemiol 2001;153:666-72.
6. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittlemark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the cardiovascular health study. Arterioscler Thromb Vasc Biol 1999;19:538-45.
7. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997;2:221-6.
8. Isiklar MH, Kulbaski M, MacDonald MJ, Lumsden AB. Infringuinal bypass in end-stage renal disease: when is it justified. Semin Vasc Surg 1997;10:42-8.
9. Hakaim AG, Gordon JK, Scott TE. Early outcome of in situ femorotibial reconstruction among patients with diabetes alone versus diabetes and end-stage renal failure: analysis of 83 limbs. J Vasc Surg 1998;27:1049-55.
10. Edwards J, Taylor LM, Porter JM. Limb salvage in end-stage renal disease. Arch Surg 1988;123:1164-8.
11. Harrington EB, Harrington ME, Schanzer H, Haimov M. End-stage renal disease: is infrainguinal limb revascularization justified. J Vasc Surg 1990;12:691-6.
12. LaMorte WW, Scott TE, Menzoian JO. Racial differences in the incidence of femoral bypass and abdominal aortic aneurysmectomy in Massachusetts: relationship to cardiovascular risk factors. J Vasc Surg 1995;21:422-31.
13. Chang JB, Stein TA. Infrainguinal revascularizations in octogenarians and septuagenarians. J Vasc Surg 2001;34:133-8.
14. TASC Working Group. Management of peripheral arterial disease (PAD). J Vasc Surg 2000;31:S1-34.
15. Menzoian JO, LaMorte WW, Paniszyn CC, McBride KJ, Sidawy AN, LoGerfo RV, et al. Symptomatology and anatomic patterns of peripheral vascular disease: differing impact of smoking and diabetes. Ann Vasc Surg 1989;3:224-8.
16. Muluk SC, Muluk VS, Kelley ME, Whittle JC, Tierney JA, Webster MW, et al. Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg 2001;33:251-8.
17. Byrne J, Darling C, Chang BB, Paty PSK, Kreienberg PB, Lloyd WE, et al. Infrainguinal arterial reconstructions for claudication: is it worth the risk? An analysis of 409 procedures. J Vasc Surg 1999;29:259-69.
18. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38.
19. Faries PL, Arora S, Pomposelli FB, Pulling MC, Smakowski P, Rohan DI, et al. The use of arm vein in lower extremity revascularization: results of 520 procedures performed in eight years. J Vasc Surg 2000; 31:50-9.
20. Burger DHC, Kappetein AP, van Bockel JH, Breslau PJ. A randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting. J Vasc Surg 2000;32:278-83.
21. Choi D, Darling RC, Roddy SP, Chang BB, Lloyd WE, Paty PSK, et al. Infrainguinal reconstruction in octogenarians: should age be a contraindication. Ann Vasc Surg 2000;14:67-72.